Vimarsana
Biggest News Aggregation in the World

Page 2 - Inst Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inst Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inst Inc Today - Breaking & Trending Today

IPR Estoppel Issues - Patent - United States - Vimarsana News

IPR Estoppel Issues - Patent - United States

The scope and applicability of inter partes review ("IPR") estoppel continues to develop and reshape patent litigation across the country.

Source: mondaq.com
Court Denies Request For Attorneys' Fees Against Counterclaimant With Ill-Defined Trade Secret - Trade Secrets - Vimarsana News

Court Denies Request For Attorneys' Fees Against Counterclaimant With Ill-Defined Trade Secret - Trade Secrets

In a late-March 2023 decision out of the U.S. District Court for the Southern District of California, a court denied a plaintiff's request for attorneys' fees against a defendant who filed "objectively specious" counterclaims ...

Source: mondaq.com
Court Denies Request for Attorneys' Fees Against Counterclaimant with Ill-Defined Trade Secret | Holland & Knight LLP - Vimarsana News

Court Denies Request for Attorneys' Fees Against Counterclaimant with Ill-Defined Trade Secret | Holland & Knight LLP

In a late-March 2023 decision out of the U.S. District Court for the Southern District of California, a court denied a plaintiff's request for attorneys' fees against a defendant who...

Inter Partes Review Estoppel Applies to All Arguments Put Forward Against Challenged Claims | Manatt, Phelps & Phillips, LLP - Vimarsana News

Inter Partes Review Estoppel Applies to All Arguments Put Forward Against Challenged Claims | Manatt, Phelps & Phillips, LLP

In California Institute of Technology v. Broadcom Limited,1 the Federal Circuit overruled prior precedent and clarified that inter partes review (IPR) estoppel applies not just to...

2021 PTAB Year in Review: Analysis & Trends: Biologics at the PTAB: Statistics and Insights into Notable Biologics Decisions | Sterne, Kessler, Goldstein & Fox P.L.L.C. - Vimarsana News

2021 PTAB Year in Review: Analysis & Trends: Biologics at the PTAB: Statistics and Insights into Notable Biologics Decisions | Sterne, Kessler, Goldstein & Fox P.L.L.C.

In June 2021, the US Patent and Trademark Office (USPTO) published an update to its study of America Invents Act (AIA) trials involving challenges to Orange Book-listed and biologic...